Scenarios of MTC in patients dealt with with liraglutide, another GLP-1 receptor agonist, are actually documented during the postmarketing period; the info in these reviews are insufficient to ascertain or exclude a causal relationship amongst MTC and GLP-1 receptor agonist use in people.In research with rodents, copyright® and medicines that per